Has Timothy Alton, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,529,099 in general payments to Timothy Alton, MD across 1,211 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Timothy Alton, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Timothy Alton, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Timothy Alton, MD

Orthopaedic Surgery · Renton, WANPI 1730404286

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $1,185,877 of the $1,529,099 with a category attached, or 77.6%. Medical Device Business Services, Inc. accounts for 70.9% of it on its own, with 11 other manufacturers making up the rest. 2025 is the largest year on record at $386,135, 5.0 times the $77,072 reported in 2019. Among orthopaedic surgery clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,529,099in general payments, 2019–2025

Across 1,211 payments — averaging $1262.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medical Device Business Services, Inc.$1.1M
KCI USA, Inc.$219K
Depuy Synthes Products, Inc.$119K
Solventum Corporation$66K
Biocomposites Inc$18K
Ethicon Endo-surgery Inc.$13K
plus $12K from 6 others

$264,701in research payments, 2019–2025

Across 24 payments — averaging $11,029 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Medical Device Business Services, Inc.$265K

What the payments were for

Consulting fees$1,185,87778%
Speaking & faculty fees$191,31913%
Travel & lodging$125,8248%
Food & beverage$26,0792%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medical Device Business Services, Inc.	774	$1,083,384
KCI USA, Inc.	171	$218,690
Depuy Synthes Products, Inc.	130	$119,155
Solventum Corporation	31	$65,648
Biocomposites Inc	11	$17,828
Ethicon Endo-surgery Inc.	2	$12,600
Johnson & Johnson	78	$7,274
Innovation Technologies Inc	4	$3,994
Zimmer Biomet	6	$467
Smith+Nephew	1	$25
Medacta USA, Inc.	1	$20
Fidia Pharma USA Inc.	2	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,529,099 in reported general payments places this provider in the 95th percentile of 495 orthopaedic surgery providers in Washington.

See all orthopaedic surgery providers in Washington →

Medicare billing

Part B allowed, 2024

$432,055

Medicare patients

443

Services billed

1,513

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Oxycodone Hcl	214	$1,756
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	20	$206
Cyclobenzaprine Hcl	15	$163
Tramadol Hcl	42	$161
Diclofenac Sodium	12	$128
Amoxicillin	113	$103
Ondansetron OdtOndansetron	11	$97
Meloxicam	38	$85
Clindamycin Hcl	36	$81

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Renton

William BarrettRenton$7.7M
Andrew MerrittRenton$59K
William HannayRenton$37K
Prashoban BremjitRenton$29K
James PritchettSeattle$6.4M
James CrutcherSeattle$3.5M
Keith MayoSeattle$3.1M
Matthew SaltzmanSeattle$1.8M
Tim LovellSpokane$1.8M
Burt YaszaySeattle$1.3M

See the full list for Washington →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →